Younger atrial fibrillation (AFib) patients are most likely to benefit from more personalized, MRI-guided ablation treatments to correct irregular heart rhythms, according to a new artificial intelligence-guided analysis of results from the DECAAF II trial, one of the largest global studies of treatments for heart arrhythmias.
Combining smoking cessation support with NHS Talking Therapies increases quit rates
Research from the University of Bath, funded by Cancer Research UK, published on No Smoking Day 2025, shows that integrating smoking cessation support into NHS